Reprocessing unsatisfactory ThinPrep Papanicolaou tests using a modified SurePath preparation technique
نویسندگان
چکیده
منابع مشابه
Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
OBJECTIVE To compare unsatisfactory rates between the two major liquid-based cytology (LBC) platforms, namely ThinPrep (Hologic) and SurePath (Becton Dickinson). DESIGN The authors performed both a systematic review and a meta-analysis. Inclusion criteria were English language, data presented on unsatisfactory rates for either ThinPrep or SurePath, utilising actual patient samples (ie, not la...
متن کاملclinicopathologic correlation of the unsatisfactory papanicolaou smear
the 1991 bethesda system for cervical/vaginal cytology reporting has defined adequacy criteria, including unsatisfactory designation. most laboratories in usa and a few laboratories in iran have implemented these criteria, but only few studies about clinical implications have been performed. all unsatisfactory papanicolaou (pap) smears taken between august 2000 and march 2002 were retrieved fro...
متن کاملComparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
BACKGROUND Split-sample clinical trials for liquid-based Papanicolaou (Pap) smears demonstrated that the liquid-based Pap smear was a safe and effective replacement for the conventional Pap smear. However, clinical intended use of liquid-based technology employs direct-to-vial collection methods. The current study compared the cytologic detection rates of the liquid-based Pap smear with convent...
متن کاملPerformance of the CellSolutions Glucyte liquid-based cytology in comparison with the ThinPrep and SurePath methods.
OBJECTIVE Glucyte liquid-based cytology (LBC; BestPrep™;CellSolutions, LLC, Greensboro, N.C., USA) is a recently developed method. Its performance was assessed in comparison with ThinPrep (Hologic Inc., Marlborough, Mass., USA) and SurePath (BD Diagnostics, Burlington, N.C., USA) LBC platforms. STUDY DESIGN Two cervical samples obtained from each of 331 patients presenting for colposcopy were...
متن کاملAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia.
OBJECTIVES The aims of this study were to assess the number of cases diagnosed as glandular neoplasia (national report code 6) of cervical (6A) and non-cervical (6B) types on ThinPrep (TP) and SurePath (SP) liquid-based cytology (LBC) samples and to calculate the positive predictive value (PPV) of these diagnoses for significant glandular and/or squamous pathology for local audit and as a contr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Cytopathology
سال: 2014
ISSN: 1934-662X,1934-6638
DOI: 10.1002/cncy.21408